| Product NDC: | 0019-N602 |
| Proprietary Name: | SODIUM IODIDE I 123 |
| Non Proprietary Name: | sodium iodide i 123 |
| Active Ingredient(s): | 200 uCi/1 & nbsp; sodium iodide i 123 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0019-N602 |
| Labeler Name: | Mallinckrodt Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA071910 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070411 |
| Package NDC: | 0019-N602-20 |
| Package Description: | 1 BOTTLE in 1 CAN (0019-N602-20) > 1 CAPSULE, GELATIN COATED in 1 BOTTLE |
| NDC Code | 0019-N602-20 |
| Proprietary Name | SODIUM IODIDE I 123 |
| Package Description | 1 BOTTLE in 1 CAN (0019-N602-20) > 1 CAPSULE, GELATIN COATED in 1 BOTTLE |
| Product NDC | 0019-N602 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium iodide i 123 |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070411 |
| Marketing Category Name | ANDA |
| Labeler Name | Mallinckrodt Inc. |
| Substance Name | SODIUM IODIDE I-123 |
| Strength Number | 200 |
| Strength Unit | uCi/1 |
| Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |